These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4037185)

  • 1. Homogeneity among Senegalese strains of yellow fever virus.
    Deubel V; Pailliez JP; Cornet M; Schlesinger JJ; Diop M; Diop A; Digoutte JP; Girard M
    Am J Trop Med Hyg; 1985 Sep; 34(5):976-83. PubMed ID: 4037185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.
    Schlesinger JJ; Brandriss MW; Monath TP
    Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Yellow fever in Senegal from 1976 to 1980 (author's transl)].
    Salaun JJ; Germain M; Robert V; Robin Y; Monath TP; Camicas JL; Digoutte JP
    Med Trop (Mars); 1981; 41(1):45-51. PubMed ID: 6792455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative immunochemical and biological analysis of African and South American yellow fever viruses.
    Deubel V; Schlesinger JJ; Digoutte JP; Girard M
    Arch Virol; 1987; 94(3-4):331-8. PubMed ID: 2437890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
    Gould EA; Buckley A; Cammack N; Barrett AD; Clegg JC; Ishak R; Varma MG
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic heterogeneity of yellow fever virus strains from Africa and the Americas.
    Deubel V; Digoutte JP; Monath TP; Girard M
    J Gen Virol; 1986 Jan; 67 ( Pt 1)():209-13. PubMed ID: 3944583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of yellow fever virus 17DD vaccine strain.
    Post PR; Santos CN; Carvalho R; Lopes OS; Galler R
    Mem Inst Oswaldo Cruz; 1991; 86(2):239-46. PubMed ID: 1842415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Integrated approach to yellow fever surveillance: pilot study in Senegal in 2003-2004].
    Faye O; Diallo M; Dia I; Ba Y; Faye O; Mondo M; Sylla R; Faye PC; Sall AA
    Bull Soc Pathol Exot; 2007 Aug; 100(3):187-92. PubMed ID: 17824313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
    Barrett AD; Mathews JH; Miller BR; Medlen AR; Ledger TN; Roehrig JT
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation among strains of wild-type yellow fever virus from Senegal.
    Wang H; Jennings AD; Ryman KD; Late CM; Wang E; Ni H; Minor PD; Barrett AD
    J Gen Virol; 1997 Jun; 78 ( Pt 6)():1349-52. PubMed ID: 9191928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis.
    Jennings AD; Gibson CA; Miller BR; Mathews JH; Mitchell CJ; Roehrig JT; Wood DJ; Taffs F; Sil BK; Whitby SN
    J Infect Dis; 1994 Mar; 169(3):512-8. PubMed ID: 7908925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yellow fever in the Gambia, 1978--1979: entomological aspects and epidemiological correlations.
    Germain M; Francy DB; Monath TP; Ferrara L; Bryan J; Salaun JJ; Heme G; Renaudet J; Adam C; Digoutte JP
    Am J Trop Med Hyg; 1980 Sep; 29(5):929-40. PubMed ID: 7435794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of wild-type yellow fever virus by passage in HeLa cells.
    Barrett AD; Monath TP; Cropp CB; Adkins JA; Ledger TN; Gould EA; Schlesinger JJ; Kinney RM; Trent DW
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2301-6. PubMed ID: 2230735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    Schlesinger JJ; Chapman S
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence.
    Monath TP; Schlesinger JJ; Brandriss MW; Cropp CB; Prange WC
    Am J Trop Med Hyg; 1984 Jul; 33(4):695-8. PubMed ID: 6206738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic distribution and evolution of yellow fever viruses based on direct sequencing of genomic cDNA fragments.
    Lepiniec L; Dalgarno L; Huong VT; Monath TP; Digoutte JP; Deubel V
    J Gen Virol; 1994 Feb; 75 ( Pt 2)():417-23. PubMed ID: 8113765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic analysis of yellow fever virus glycoproteins: use of monoclonal antibodies in enzyme-linked immunosorbent assays.
    Cammack N; Gould EA
    J Virol Methods; 1986 May; 13(2):135-42. PubMed ID: 3016014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
    Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
    J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.